597 related articles for article (PubMed ID: 15249360)
21. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.
Tanga L; Centofanti M; Oddone F; Parravano M; Parisi V; Ziccardi L; Kroegler B; Perricone R; Manni G
Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):715-21. PubMed ID: 21253758
[TBL] [Abstract][Full Text] [Related]
22. Effect of stopping hydroxychloroquine therapy on the multifocal electroretinogram in patients with rheumatic disorders.
Adamptey B; Rudnisky CJ; MacDonald IM
Can J Ophthalmol; 2020 Feb; 55(1):38-44. PubMed ID: 31712033
[TBL] [Abstract][Full Text] [Related]
23. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.
Browning DJ
Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706
[TBL] [Abstract][Full Text] [Related]
24. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy].
Karkanová M; Matusková V; Vlková E; Dosková H; Uhmannová R
Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239
[TBL] [Abstract][Full Text] [Related]
25. Subjective and objective screening tests for hydroxychloroquine toxicity.
Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
[TBL] [Abstract][Full Text] [Related]
26. Using multifocal ERG ring ratios to detect and follow Plaquenil retinal toxicity: a review : Review of mfERG ring ratios in Plaquenil toxicity.
Lyons JS; Severns ML
Doc Ophthalmol; 2009 Feb; 118(1):29-36. PubMed ID: 18465156
[TBL] [Abstract][Full Text] [Related]
27. Retinal disorders in northern Brazilian patients treated with chloroquine assessed by multifocal ERG.
Raster M; Horn F; Jünemann A; Rosa AA; Souza GS; Gomes BD; Lima MG; Silveira LC; Kremers J
Doc Ophthalmol; 2011 Apr; 122(2):77-86. PubMed ID: 21290166
[TBL] [Abstract][Full Text] [Related]
28. Missing the bull's eye.
Gilbert ME; Savino PJ
Surv Ophthalmol; 2007; 52(4):440-2. PubMed ID: 17574068
[TBL] [Abstract][Full Text] [Related]
29. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test.
Tsang AC; Ahmadi Pirshahid S; Virgili G; Gottlieb CC; Hamilton J; Coupland SG
Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328
[TBL] [Abstract][Full Text] [Related]
30. ERG findings in patients using hydroxychloroquine.
Tzekov RT; Serrato A; Marmor MF
Doc Ophthalmol; 2004 Jan; 108(1):87-97. PubMed ID: 15104171
[TBL] [Abstract][Full Text] [Related]
31. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.
Borrelli E; Battista M; Cascavilla ML; Viganò C; Borghesan F; Nicolini N; Clemente L; Sacconi R; Barresi C; Marchese A; Miserocchi E; Modorati G; Bandello F; Querques G
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):28. PubMed ID: 34581725
[TBL] [Abstract][Full Text] [Related]
32. Comparison between multifocal ERG and C-Scan SD-OCT ("en face" OCT) in patients with a suspicion of antimalarial retinal toxicity: preliminary results.
Arndt C; Costantini M; Chiquet C; Afriat M; Berthemy S; Vasseur V; Ducasse A; Mauget-Faÿsse M
Doc Ophthalmol; 2018 Apr; 136(2):97-111. PubMed ID: 29536324
[TBL] [Abstract][Full Text] [Related]
33. Validation of the colour difference plot scoring system analysis of the 103 hexagon multifocal electroretinogram in the evaluation of hydroxychloroquine retinal toxicity.
Graves GS; Adam MK; Stepien KE; Han DP
Acta Ophthalmol; 2014 Aug; 92(5):e377-81. PubMed ID: 25043791
[TBL] [Abstract][Full Text] [Related]
34. The multifocal pattern electroretinogram in chloroquine retinopathy.
Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G
Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107
[TBL] [Abstract][Full Text] [Related]
35. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
36. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
[TBL] [Abstract][Full Text] [Related]
37. Abnormal multifocal electroretinogram (mfERG) in ethambutol toxicity.
Kardon RH; Morrisey MC; Lee AG
Semin Ophthalmol; 2006; 21(4):215-22. PubMed ID: 17182409
[TBL] [Abstract][Full Text] [Related]
38. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
[TBL] [Abstract][Full Text] [Related]
39. Electrophysiological and SD-OCT findings in patients receiving chloroquine therapy in relation to cumulative dosage and duration of treatment.
Bertoli F; Šuštar M; Jarc Vidmar M; Perovšek D; Brecelj J; Markelj Š; Jaki Mekjavić P; Šuput D; Tomšič M; Isola M; Battistella C; Lanzetta P; Hawlina M
Doc Ophthalmol; 2020 Aug; 141(1):1-14. PubMed ID: 31927702
[TBL] [Abstract][Full Text] [Related]
40. Assessment of hydroxychloroquine maculopathy after cessation of treatment: an optical coherence tomography and multifocal electroretinography study.
Moschos MM; Nitoda E; Chatziralli IP; Gatzioufas Z; Koutsandrea C; Kitsos G
Drug Des Devel Ther; 2015; 9():2993-9. PubMed ID: 26089648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
